PBLA - What's Going On With Panbela Therapeutics Stock Today? | Benzinga
Panbela Therapeutics, Inc. (NASDAQ:PBLA) shares are trading lower over 2% on Tuesday, ending Monday’s session with a whopping 65.3% decline on the bourses.
On Tuesday, the company said that an abstract for SBP-101, a proprietary polyamine analogue, had been accepted for poster presentation at the American Association for Cancer Research.
The work reflects the company’s ongoing collaboration with Johns Hopkins ...